SCHEMBL6653062

SCHEMBL6653062

C[N+](CCN1CCOCC1)c1ccncc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
DYRK1A Q13627 2/20 0.40
LMNA P02545 2/20 0.40
MAPK13 O15264 2/20 0.40
MAPK12 P53778 2/20 0.40
MAPK11 Q15759 2/20 0.40
MAPK14 Q16539 2/20 0.40
NFATC1 O95644 1/20 0.40
GSK3B P49841 1/20 0.40
CXCR4 P61073 1/20 0.39
KDM4E B2RXH2 2/20 0.39
GAA P10253 2/20 0.38
MKNK1 Q9BUB5 1/20 0.38
NPC1 O15118 1/20 0.38
GLA P06280 1/20 0.38
POLB P06746 1/20 0.38
RAD52 P43351 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6704731 0.84 CYP1A2 (0.53) CYP3A4RAB9AALDH1A1CYP1A2CHRM2
SCHEMBL4331523 0.71 TDP1 (0.70) CYP3A4CYP2D6CYP2C19KDM4EGAA
SCHEMBL6653067 0.69 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C19DYRK1ALMNA
SCHEMBL6671574 0.68 CYP3A4 (0.49) CYP3A4CYP2D6CYP2C19DYRK1ALMNA
SCHEMBL6671580 0.68 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C19LMNAKDM4E
SCHEMBL6634823 0.67 HRH3 (0.66) CYP3A4CYP2D6CYP2C19DYRK1ALMNA
SCHEMBL11856358 0.66 KDM4E (0.70) KDM4EGLAPOLBALDH1A1SIGMAR1
Hydrochloric Acid SCHEMBL11142875 0.66 HRH3 (0.63) CYP3A4CYP2D6CYP2C19DYRK1ALMNA
SCHEMBL6649246 0.66 CYP3A4 (0.54) CYP3A4CYP2D6CYP2C19DYRK1ALMNA
SCHEMBL6649751 0.66 CYP2C19 (0.65) CYP3A4CYP2D6CYP2C19LMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1478645-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS Amgen Inc. (US) 2004-11-24 EP disclosed
WO-2003066630-A2 QUINOLINONE DERIVATIVES FOR TREATING CELL PROLIFERATION RELATED DISORDERS AMGEN INC. (US) 2003-08-14 WO disclosed